Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial

Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis

(2019) Yidian Dong et al.   CLINICAL RHEUMATOLOGY

Psoriasis treatment patterns: a retrospective claims study

(2019) Sara Higa et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis

(2019) Qian Yu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis

(2018) A. Egeberg et al.   BRITISH JOURNAL OF DERMATOLOGY

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

(2017) Paula Dávila-Seijo et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Biologic drug survival in Israeli psoriasis patients

(2017) Guy Shalom et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven products

(2017) Brian Hassett et al.   mAbs

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

(2017) Kim A. Papp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Etanercept and methotrexate combination therapy for the treatment of moderate to severe psoriasis: A retrospective multicentre study

(2016) Carlos Muñoz-Santos et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population

(2016) Jitian Li et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Treatment of psoriasis with etanercept: the typical patient profile

(2016) J.C. Prinz et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis

(2012) A.B. Gottlieb et al.   BRITISH JOURNAL OF DERMATOLOGY

A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis

(2012) Xiao-Xiang Chen et al.   CLINICAL RHEUMATOLOGY

Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases

(2012) Rafael Denadai et al.   Journal of Crohns & Colitis

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study

(2011) N. B. Klarenbeek et al.   ANNALS OF THE RHEUMATIC DISEASES

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2011) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The Combination of Etanercept and Methotrexate Increases the Effectiveness of Treatment in Active Psoriasis Despite Inadequate Effect of Methotrexate Therapy

(2008) C Zachariae et al.   ACTA DERMATO-VENEREOLOGICA

Etanercept combined with methotrexate for high-need psoriasis

(2008) R.J.B. Driessen et al.   BRITISH JOURNAL OF DERMATOLOGY